Teva Pharmaceuticals Down 12% on Massive Volume, Faces Billions in Opioid Related Lawsuits, Barrons Reports

Navin Jacob of UBS recently downgraded the company from a buy to neutral

-Total damages could be as high as $4 billion

-1,500 lawsuits are currently pending connected to its opioid drugs

-TEVA announced over the weekend that it has already settled one lawsuit, paying out $85 million

“Teva Pharmaceuticals Could Face Billions in Damages From Opioid Lawsuits, Analyst Says”, Barrons Reports

%d bloggers like this: